Bridging the Translational Gap in Autoimmune Drug Discovery

Bridging the Translational Gap in Autoimmune Drug Discovery is an ACS-hosted professional event presented by WuXi AppTec that examines disease-relevant research models for immune-mediated diseases. The session uses case studies in Inflammatory Bowel Disease (IBD) and Systemic Lupus Erythematosus (SLE) to explore TL1A-targeted therapies and B-cell depletion strategies. It covers strategies for benchmarking and validating emerging modalities and discusses leveraging integrated CRDMO capabilities to accelerate translational research toward IND submission.

Register through the ACS event registration link